Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (161-170 of 218) with videos related to

Pageof 22
Sort By:
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancerHeather L McArthur, Hope Rugo, Benjamin Nulsen, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
Breast Cancer Research and Treatment|April 28, 2016
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriersDana Madorsky-Feldman, Miri Sklair-Levy, Tamar Perri, et al.
JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Pageof 22

Showing results (161-170 of 218) with videos related to

Sort By:
Pageof 22
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancerHeather L McArthur, Hope Rugo, Benjamin Nulsen, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
Breast Cancer Research and Treatment|April 28, 2016
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriersDana Madorsky-Feldman, Miri Sklair-Levy, Tamar Perri, et al.
JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Pageof 22